drugset
Drugs / Cannabidivarin
last change Oct 2024 re-read 3 minutes ago

Cannabidivarin

also known as GWP42006 · CBDV · Cannabidivarol

Small molecule

Developed for
autism spectrum disorder · focal epilepsy · Prader-Willi syndrome
Investigated by
Jazz Pharmaceuticals · GW Pharmaceuticals Ltd · Eric Hollander · Foundation for Prader-Willi Research · King's College London · Montefiore Medical Center
+1 more · United States Department of Defense

Trials 7

today NCT03848481 · Ph 2 NCT03849456 · Ph 2 NCT03202303 · Ph 2 NCT03537950 · not/applicable NCT02365610 · Ph 2 NCT02369471 · Ph 2 NCT01918735 · Ph 1
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01918735 Aug → Dec 2013 epilepsy Jazz Pharmaceuticals Completed No outcome recorded
Phase 25 trials · 1 missed
Phase 2 NCT03848481 Nov 2020 → Oct 2024 Prader-Willi syndrome Eric Hollander Terminated No outcome recorded Stop: Business
Phase 2 NCT03849456 Jan → May 2020 autism spectrum disorder Jazz Pharmaceuticals Terminated No outcome recorded Stop: Enrollment
Phase 2 NCT03202303 Apr 2019 → Feb 2027 expected autism spectrum disorder Montefiore Medical Center Recruiting No outcome recorded
Phase 2 NCT02365610 Mar 2016 → Jul 2017 focal epilepsy Jazz Pharmaceuticals Completed Missed primary
Phase 2 NCT02369471 Mar → Oct 2015 focal epilepsy Jazz Pharmaceuticals Completed No outcome recorded
Phase not applicable1 trial
— NCT03537950 Aug 2016 → Feb 2017 autism spectrum disorder King's College London Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as Cannabidivarin “Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)” NCT03848481 ↗
1

NCT03202303 ↗
Known as Cannabidivarol ChEMBL registry synonym — accepted as the source's own label CHEMBL2387742 ↗
Known as CBDV “Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)” NCT03848481 ↗
2

“Cannabidivarin (CBDV) is a nonpsychoactive phytocannabinoid and a safe variant of Cannabidiol (CBD).” NCT03202303 ↗

NCT03537950 ↗
Known as GWP42006 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03849456 ↗
3

NCT02365610 ↗

NCT02369471 ↗

NCT01918735 ↗
Modality Small molecule — CHEMBL2387742 ↗
Route Oral “Oral administration of 25” NCT01918735 ↗